Nektar Therapeutics (NKTR)

[SeriousMoney]

MICHAEL SHULMAN: Editor ChangeWave Biotech Investor

http://www.leadingauthorities.com/Talent/S/Shulman_Michael/Shulman_Michael.doc



Michael Shulman is currently the Managing Director of Research for ChangeWave Investment Research. Michael joined ChangeWave after spending twenty years in various high tech industries. Prior to joining ChangeWave Michael was the CEO of AtYourBusiness.com, now Primewire, a benefits administration Application Service Provider he founded in 1998.

Michael began his career doing in-depth company and market analysis for a variety of companies, building databases and simulation models to estimate the success of various technologies across a wide range of market segments. He moved "inside" the high tech community as a manager at high-tech companies including AT&T. Michael was an early private investor in several Internet start-ups, notably XOOM.com (went public in 1998 and was bought by NBC in 1999) and brings a unique perspective to the ChangeWave research effort, as a combination of technologist, investor and financial analyst.

Michael currently sits on the Executive Board of NextGen Capital, a venture fund based in Fairfax, Virginia, Chairman and Board member of Primewire, and sits on the Advisory Boards of Sandbox.com and Brainbench.

He has published in a variety of trade and general business publications, including CD-ROM Today, Worth Online, The Motley Fool, Bonjour Paris and The Los Angeles Times.

Michael began work for Phillips Investment Resources by performing independent research and financial analysis for several of its publications. Prior to taking on his current role as Editor of the ChangeWave Biotech Investor he was Editor of ChangeWave Hedge Fund Investing.